Skip to main content
. Author manuscript; available in PMC: 2012 Aug 1.
Published in final edited form as: Cancer Res. 2009 Sep 8;69(18):7243–7251. doi: 10.1158/0008-5472.CAN-09-0167

Figure 3.

Figure 3

Endothelial cell proliferation and tubule formation in vitro in response to CSC-low and CSC-high conditioned medium. A and B, HUVEC proliferation assays ± IMC1121-b (anti-VEGFR2) or AMD3100. CPM, counts/min, 10 wells per group. C, HUVEC tubule formation assays ± IMC1121-b or AMD3100. Data are the sum of lengths (in pixels) of all tubules per field at ×100. Four wells per group, 10 fields per well.

HHS Vulnerability Disclosure